Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
1.325
-0.015 (-1.12%)
Apr 29, 2026, 1:39 PM CET
-56.70% (1Y)
| Market Cap | 40.73M |
| Revenue (ttm) | 32.78M |
| Net Income (ttm) | -28.48M |
| Shares Out | 30.40M |
| EPS (ttm) | -0.98 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,985 |
| Average Volume | 80,407 |
| Open | 1.350 |
| Previous Close | 1.340 |
| Day's Range | 1.300 - 1.350 |
| 52-Week Range | 0.760 - 3.400 |
| Beta | 1.09 |
| RSI | 64.54 |
| Earnings Date | Apr 15, 2026 |